Trial Profile
Fipamezole in patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Apr 2011
Price :
$35
*
At a glance
- Drugs Fipamezole (Primary) ; Levodopa
- Indications Parkinson's disease
- Focus Therapeutic Use
- 14 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
- 05 Nov 2010 New trial record.